UK Study Identifies Potential Target for Bacteria Behind Tooth Decay
LEXINGTON, Ky. (Aug. 6, 2021) — Findings from a University of Kentucky College of Medicine study could lead to a new way to combat the bacteria responsible for tooth decay.
The research led by Natalia Korotkova, assistant professor in the UK Department of Microbiology, Immunology and Molecular Genetics, identified a potential therapeutic target in Streptococcus mutans, bacteria that lives in the mouth and causes tooth decay.
“The findings could be promising to the development of a therapy that could prevent cavities by specifically targeting S. mutans,” Korotkova said.
Current methods for reducing plaque including mechanical cleansing, mouthwashes and conventional antibiotics have limited effects against already-established colonies of the bacteria, says Korotkova. In addition, they can also kill healthy, beneficial oral bacteria.
Korotkova’s team identified polysaccharide decorations in the cell wall of S. mutans that are necessary for the bacteria to divide correctly and reproduce, which makes the enzymes that make them attractive targets for future drug development.
Korotkova says understanding how cell wall polysaccharides regulate bacterial cell division is also helping to answer a long-standing fundamental question in microbiology: How do bacteria maintain their exact shape?
“The findings will open new venues for investigation of the factors controlling cell morphology in other bacteria and development of the approaches to manipulate it,” Korotkova said.
Study results were published in the August 2021 edition of Nature Chemical Biology.
Research reported in this publication was supported by the National Institute of Dental and Craniofacial Research of the National Institutes of Health under Award Number R01DE028916 and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI143690. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
As the state’s flagship, land-grant institution, the University of Kentucky exists to advance the Commonwealth. We do that by preparing the next generation of leaders — placing students at the heart of everything we do — and transforming the lives of Kentuckians through education, research and creative work, service and health care. We pride ourselves on being a catalyst for breakthroughs and a force for healing, a place where ingenuity unfolds. It's all made possible by our people — visionaries, disruptors and pioneers — who make up 200 academic programs, a $476.5 million research and development enterprise and a world-class medical center, all on one campus.
In 2022, UK was ranked by Forbes as one of the “Best Employers for New Grads” and named a “Diversity Champion” by INSIGHT into Diversity, a testament to our commitment to advance Kentucky and create a community of belonging for everyone. While our mission looks different in many ways than it did in 1865, the vision of service to our Commonwealth and the world remains the same. We are the University for Kentucky.